Patient Guide: A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 176 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04965493
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 176 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chandler, Arizona
  • Phoenix, Arizona
  • Orange, California
  • • And 173 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily